CASI Pharmaceuticals
CASI
#11089
Rank
NZ$7.61 M
Marketcap
NZ$0.37
Share price
0.00%
Change (1 day)
-84.44%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2025 (TTM): -NZ$81.48 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are NZ$26.84 Million. In 2024 the company made an earning of -NZ$68 Million a decrease over its 2023 earnings that were of -NZ$47.11 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$81.48 Million19.82%
2024 -NZ$68 Million44.35%
2023 -NZ$47.11 Million-29.55%
2022 -NZ$66.86 Million4.43%
2021 -NZ$64.02 Million-24.56%
2020 -NZ$84.86 Million4.74%
2019 -NZ$81.03 Million65.13%
2018 -NZ$49.07 Million155.07%
2017 -NZ$19.24 Million13.93%
2016 -NZ$16.89 Million31.18%
2015 -NZ$12.88 Million-72.5%
2014 -NZ$46.8 Million356.62%
2013 -NZ$10.25 Million-60.55%
2012 -NZ$25.98 Million218.41%
2011 -NZ$8.16 Million0.74%
2010 -NZ$8.1 Million-32.54%
2009 -NZ$12.01 Million-66.98%
2008 -NZ$36.36 Million-14.22%
2007 -NZ$42.39 Million7.04%
2006 -NZ$39.6 Million27.95%
2005 -NZ$30.95 Million4.51%
2004 -NZ$29.62 Million-15.84%
2003 -NZ$35.19 Million-55.29%
2002 -NZ$78.71 Million-34.05%
2001 -NZ$0.12 Billion31.73%
2000 -NZ$90.59 Million31.56%
1999 -NZ$68.86 Million145.56%
1998 -NZ$28.05 Million76.4%
1997 -NZ$15.9 Million36.92%
1996 -NZ$11.61 Million